Less-invasive RFA method seen as a complementary treatment UT Health San Antonio Multispecialty and Research Hospital became the first in South Texas to use an emerging and less-invasive treatment called radiofrequency ablation on a comorbid patient with a pancreatic cancer tumor that couldn’t be removed by surgery. The method, RFA for short, delivers controlled heat in […]

UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), received nearly $3 million in new academic and prevention awards as part of the latest, almost $154 million funding round announced on November 19 by the Cancer Prevention Research Institute of Texas (CPRIT). This brings CPRIT’s […]

  Research scientists and clinicians at UT Health San Antonio are working to halt one of the most persistent bacterial infections that silently affects millions of people worldwide. Helicobacter pylori (H. pylori) is a spiral-shaped bacterium capable of burrowing into the stomach lining and is the only bacterium known to directly cause cancer. Through leading […]

UT Health San Antonio’s advanced endoscopy team leads efforts in early detection and prevention Gastrointestinal cancers were previously believed to primarily affect older adults, but over the past two decades, rates of these cancers have increased dramatically in people under age 50. A new report from the Dana-Farber Cancer Institute reveals that colorectal, pancreatic, esophageal […]

UT Health San Antonio’s Advanced Interventional Gastroenterology Program is now offering an advanced, minimally invasive procedure that allows physicians to remove large, early-stage colorectal lesions without the need for traditional surgery.

UT Health San Antonio’s Mays Cancer Center has been named among the nation’s leading hospitals and health systems for excellence in oncology programs, according to Becker’s Hospital Review.

UT Health San Antonio’s Mays Cancer Center is hosting a Grand Rounds Oct. 15 — Global Lobular Breast Cancer Awareness Day — to spotlight new approaches to diagnosis and treatment of invasive lobular carcinoma, a common but often overlooked form of breast cancer.

Elizabeth Wasmuth, PhD, assistant professor in the Department of Biochemistry and Structural Biology of the Joe R. and Teresa Lozano Long School of Medicine and co-director of the cryo-EM facility at The University of Texas at San Antonio, has been selected by the Howard Hughes Medical Institute (HHMI) as a Freeman Hrabowski Scholar. The five-year […]

FOXM1 protein identified as key driver in immunotherapy resistance, unlocking new therapeutic avenues   For years, scientists have found the overexpression of a specific protein called FOXM1 in a wide range of cancers, including ovarian, breast and pediatric cancers. A recent study by scientists at The University of Texas Health Science Center at San Antonio […]

A cancer diagnosis is always devastating and is especially overwhelming when the patient is a child. This is why the CURE Childhood Cancer Foundation is on a mission to advance research that will bring an end to childhood cancers. Recently, Raushan Kurmasheva, PhD, assistant professor at the Greehey Children’s Cancer Research Institute and Department of […]